Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sky Biologics is a regenerative medicine company dedicated to the development and commercialization of advanced human tissue-based products. The company specializes in allografts derived from amniotic tissue, placental membranes, and bone, which are designed to enhance the body's natural healing processes. Their product portfolio, including the SKY Amnio and SKY Dermis lines, serves clinicians in the fields of orthopedics, sports medicine, and chronic wound management. By utilizing proprietary processing techniques, Sky Biologics provides high-quality biologic solutions that offer structural support and regenerative properties for complex surgical and outpatient procedures. The company is headquartered in California and focuses on improving patient outcomes through the science of birth-tissue-derived therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SKY Biologics.